Modernizing cosmetic chemical safety assessment: an updated workflow
Abstract
We present an updated workflow for safety assessment of human systemic toxicity of cosmetic chemicals that is exposure-led and hypothesis-driven and adapted from that proposed by the SEURAT-1 European program, taking account of day-to-day realities faced by cosmetic ingredient risk assessors. The workflow utilizes pre-existing legacy in vivo toxicity data for target chemicals and chemically and biologically suitable analogs. These are considered alongside human exposure data and are complemented by data provided by in silico and in vitro new-approach methodologies, when needed to build confidence in the safety decision or when legacy in vivo toxicity data are unavailable. The workflow specifies three consecutive Tiers. Tier 0 involves problem formulation and collection of existing data; if this provides sufficient certainty in a safety decision, further work is not needed. Tier 1 focuses on further hypothesis generation, plus data generation to explore (and potentially generate) hypotheses and quantify points of departure. Tier 2 encompasses further refinement activities that may be required if activities undertaken in Tiers 0 and 1 are insufficient. The workflow differs from existing frameworks by providing clear exit points, explicit integration of new approach methodologies-supported read-across and a practical structure for systemic toxicity decision-making without new animal data generation. We have highlighted aspects that will benefit from further development and improvement—most notably, Tier 2 refinement. Case studies are presented that illustrate how the updated workflow is ready for practical use in cosmetic chemical safety assessments. We recommend its adoption in future cosmetic ingredient regulatory submissions.
Related
- Dual asymmetric centrifugation to prepare cosmetic emulsions and creams: Physico‐chemical and energy considerations
- WHO estimates of the global, regional, and national burden of 42 foodborne infectious and chemical hazards, 2000–21: an updated data synthesis
- A non-destructive methodological framework for modernizing legacy clinical reporting systems for AI-driven pharmacoinformatics: a SAS case study
- Thyroid Eye Disease in the Teprotumumab Era: Pathophysiology, Clinical Activity Assessment, and an Updated Therapeutic Landscape
- CHARMS and PROBAST+AI: an updated template for Data Extraction and Risk of Bias Assessment in systematic reviews of prediction models
BibTeX
@article{dent2026modernizing,
title = {{Modernizing cosmetic chemical safety assessment: an updated workflow}},
author = {Matthew P Dent and Catherine Mahony and Abdulkarim Najjar and Gladys Ouedraogo and David Allen and Andreea Cuciureanu and Arianna Giusti and Fabrice Nesslany and Andreas Schepky and Harald Streicher and J Gerald Kenna},
journal = {Toxicological Sciences},
year = {2026},
month = oct,
doi = {10.1093/toxsci/kfag139},
url = {https://doi.org/10.1093/toxsci/kfag139},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Modernizing cosmetic chemical safety assessment: an updated workflow
AU - Matthew P Dent
AU - Catherine Mahony
AU - Abdulkarim Najjar
AU - Gladys Ouedraogo
AU - David Allen
AU - Andreea Cuciureanu
AU - Arianna Giusti
AU - Fabrice Nesslany
AU - Andreas Schepky
AU - Harald Streicher
AU - J Gerald Kenna
PY - 2026
DA - 2026/10/24
JO - Toxicological Sciences
DO - 10.1093/toxsci/kfag139
UR - https://doi.org/10.1093/toxsci/kfag139
AB - We present an updated workflow for safety assessment of human systemic toxicity of cosmetic chemicals that is exposure-led and hypothesis-driven and adapted from that proposed by the SEURAT-1 European program, taking account of day-to-day realities faced by cosmetic ingredient risk assessors. The workflow utilizes pre-existing legacy in vivo toxicity data for target chemicals and chemically and biologically suitable analogs. These are considered alongside human exposure data and are complemented by data provided by in silico and in vitro new-approach methodologies, when needed to build confidence in the safety decision or when legacy in vivo toxicity data are unavailable. The workflow specifies three consecutive Tiers. Tier 0 involves problem formulation and collection of existing data; if this provides sufficient certainty in a safety decision, further work is not needed. Tier 1 focuses on further hypothesis generation, plus data generation to explore (and potentially generate) hypotheses and quantify points of departure. Tier 2 encompasses further refinement activities that may be required if activities undertaken in Tiers 0 and 1 are insufficient. The workflow differs from existing frameworks by providing clear exit points, explicit integration of new approach methodologies-supported read-across and a practical structure for systemic toxicity decision-making without new animal data generation. We have highlighted aspects that will benefit from further development and improvement—most notably, Tier 2 refinement. Case studies are presented that illustrate how the updated workflow is ready for practical use in cosmetic chemical safety assessments. We recommend its adoption in future cosmetic ingredient regulatory submissions.
SN - 1096-6080
SN - 1096-0929
ER -